Biomolecular markers of outcome prediction in prostate cancer-Reference-Cited by-同舟云学术

Biomolecular markers of outcome prediction in prostate cancer

Published:2009-06-19 Issue:S13 Volume:115 Page:3058-3067
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Lopergolo Alessia,Zaffaroni Nadia

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.24346/fullpdf

Reference48 articles.

1. Prognostic significance of p16 and CDK4 proteins in localized prostate carcinoma;Halvorsen;Cancer.,2000

2. Overexpression of the cell cycle inhibitor p16INK4A in high-grade prostatic intraepithelial neoplasia predicts early relapse in prostate cancer patients;Henshall;Clin Cancer Res.,2001

3. Loss of p16 expression is of prognostic significance in locally advanced prostate cancer: an analysis from the radiation therapy oncology group protocol 86-10;Chakravarti;J Clin Oncol.,2003

4. Prognostic value of p16 in locally advanced prostate cancer: a study based on radiation therapy oncology group protocol 9202;Chakravarti;J Clin Oncol.,2007

5. Expression of p21 cell cycle protein is an independent predictor of response to salvage radiotherapy after radical prostatectomy;Rigaud;Prostate.,2004

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex hormone-binding globulin and its critical role in prostate cancer: A comprehensive review;The Journal of Steroid Biochemistry and Molecular Biology;2025-01

2. INTERRELATION BETWEEN EXPRESSION OF BONE TISSUE REMODELING MARKERS AND MARKERS OF MOLECULAR PROFILE OF BREAST NEOPLASMS INVOLVED IN MECHANISMS OF INITIATION AND DEVELOPMENT OF BONE METASTASES;Oncology;2023

3. Can epigenetic and inflammatory biomarkers identify clinically aggressive prostate cancer?;World Journal of Clinical Oncology;2020-02-24

4. Cyclooxygenase 2 (rs2745557) Polymorphism and the Susceptibility to Benign Prostate Hyperplasia and Prostate Cancer in Egyptians;Biochemical Genetics;2016-02-26

5. Molecular markers to guide primary radical treatment selection in localized prostate cancer;Expert Review of Molecular Diagnostics;2014-07-04